HG-1252

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameHG-1252

Drug Alias NameCECR-1 modulator (Human Genome Sciences)cat eye syndrome chromosome region, candidate 1 modulator (Human Genome Sciences)cat eye syndrome critical region protein 1 modulator (Human Genome Sciences)dendritic cell-derived growth factor modulator (Human Genome Sciences)IDGFL modulator (Human Genome Sciences) +[7]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsCardiovascular Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHuman Genome Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHuman Genome Sciences Inc

Active IndicationsN/A

Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A